Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05628194 · ClinicalTrials.gov registry record
Assessing THE GAY Male Experience With Anal Cancer Prevention Strategies
A clinical trial of Anal Cancer, sponsored by University of Minnesota.
- Recruiting
- Registry status
- 5,000
- Enrollment target
- 1
- Study location
NCT05628194 is a study of Anal Cancer that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 5,000 participants, above the 317-participant average among 19 other Anal Cancer trials with a reported enrollment target (1477% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05628194, a study of Anal Cancer, is actively recruiting participants, sponsored by University of Minnesota.
- RECRUITING
- Registry status
- 5,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to describe current knowledge and opinions about anal cancer screening among men who have sex with men (MSM), as well as their experience receiving guideline-compliant care aimed at anal cancer risk reduction using a large-scale survey disseminated via social media.
Conditions Studied
Interventions
- OTHER Observational/Survery
Study Locations (1)
Minnesota
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 2023-06-08 |
| Est. Completion | 2026-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05628194
The ClinicalTrials.gov registry entry for NCT05628194 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 5,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 317-participant average among 19 other Anal Cancer trials with a reported enrollment target (1477% higher). The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Anal Cancer appearing as the primary indexed condition, and to 1 intervention - of which Observational/Survery is the first listed.
NCT05628194 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT05628194 about?
NCT05628194 is a clinical study titled "Assessing THE GAY Male Experience With Anal Cancer Prevention Strategies". The purpose of this study is to describe current knowledge and opinions about anal cancer screening among men who have sex with men (MSM), as well as their experience receiving guideline-compliant care aimed at anal cancer risk reduction using a large-scale survey disseminated via social media.
What is the current status of trial NCT05628194?
This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2023-06-08. Estimated completion is 2026-06-30.
What conditions does trial NCT05628194 study?
This clinical trial studies the following conditions: Anal Cancer.
What interventions are being tested in trial NCT05628194?
The interventions under investigation include: Observational/Survery (OTHER).
Who is sponsoring clinical trial NCT05628194?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05628194 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Self-sampling to Optimize Anal Lesion Outcomes
RECRUITING · NA
-
E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
RECRUITING · Phase 2
-
Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women
RECRUITING
-
Study of Pembrolizumab, Carboplatin, Paclitaxel, and Radiation for the Treatment of Early-Stage Anal Cancer
RECRUITING · Phase 2
-
Integrated Cancer Repository for Cancer Research
RECRUITING
-
EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.